Objective Mepolizumab proved to be an efficacious treatment for eosinophilic granulomatosis
with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the randomized, controlled …

Osteoarthritis (OA) is the most prevalent chronic rheumatic diseases worldwide, with a
strong impact on individual and population health. OA is a clinically heterogeneous disease …

Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …

Anti Jo-1 antibodies are the main markers of the antisynthetase syndrome (ASSD), an
autoimmune disease clinically characterized by the occurrence of arthritis, myositis, and interstitial …

The clinical spectrum and prognosis of systemic sclerosis (SSc) seem to vary among patients'
populations recruited during different time periods. In order to verify this possible evolution …

Background Interstitial lung disease (ILD) is the most severe extra‐articular manifestation of
rheumatoid arthritis (RA). Although it is responsible of 10–20% of all RA mortality, no …

The opportunity of a multidisciplinary evaluation for the diagnosis of interstitial pneumonias
highlighted a major change in the diagnostic approach to diffuse lung disease. The new …

Objective To evaluate clinical associations of anti-PM/Scl antibodies in patients with SSc in
a multicentre international cohort, with particular focus on unresolved issues, including …

Anti-Jo-1 is the most frequently detectable antibody in the antisynthetase syndrome (ASSD),
an autoimmune disease characterized by the occurrence of arthritis, myositis, and interstitial …

Background: Treatment of rheumatoid arthritis (RA)-related interstitial lung disease (ILD) is
challenging, and many conventional and biologic disease-modifying anti-rheumatic drugs (…